RecruitingPhase 3NCT06966245

External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia

External Mastalgia-oil Versus Placebo in Premenopausal Women With Severe Mastalgia: a Double-blind, Randomized Clinical Trial

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Enrollment

190 participants

Start Date

Jun 8, 2025

Study Type

INTERVENTIONAL

Conditions

Mastalgia

Summary

This is a single-center, double-blind, randomized clinical trial to explore the efficacy and safety of external mastalgia-oil versus placebo in premenopausal women with severe mastalgia.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Mastalgia-oil placebo and a drug called mastalgia-oil for people with mastalgia. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGmastalgia-oil

External mastalgia-oil 1 ml/d per breast for 3 consecutive menstrual cycles

DRUGMastalgia-oil placebo

External mastalgia-oil placebo 1 ml/d per breast for 3 consecutive menstrual cycles

Locations(1)

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Guangzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06966245

Related Trials